New Myeloma Treatments | Jeffrey Matous, M.D. | Colorado Blood Cancer Institute

New Myeloma Treatments | Jeffrey Matous, M.D. | Colorado Blood Cancer Institute


– What are some of these new treatments that we have in multiple myeloma? Well, it falls into a number
of different categories. And so, in myeloma, we have a number of different medications that attack the myeloma cells from different angles, if you will. And many of these new treatments have been approved in the last few years. And just in this last,
in November of 2015, we had three drugs approved in a single month by the FDA. Let’s talk about ’em. One of those is a pill called ixazomib. And ixazomib is a funny name, but it’s an oral form of, related to a medication
that we commonly give called bortezomib,
VELCADE, to treat myeloma. And just having this drug
available in an oral form will make it possible for patients to maybe come into the
clinic a little bit less and self-administer many
of their treatments. And that’s a big quality of life matter for patients with myeloma. The other two recently
approved medicines by the FDA are a completely new kind of
medicine for treating myeloma. They’re called monoclonal antibodies. They work with the immune system to help treat patients with myeloma and kill the myeloma cells. One of those drugs is called elotuzumab and the other one is called daratumumab. And these are medicines that we were fortunate
enough to be involved with in research here at CBCI
before they were approved. And they’re medicines that
clearly are going to improve the way that we take care of
our patients with myeloma. So we’re very excited about those. And those are just some
of the new treatments that we have in myeloma.